For a full list of today's Salon Technology stories, go to the Technology home page. There are a few ways to evade spammers, but most will limit your reception of other mail too.
Legitimate businesses threaten our e-mail system with their misguided marketing efforts.
Incyte CEO Roy Whitfield gives biotech investors and patent critics a few lessons on genomic research. British-born Roy Whitfield had in mind when he first headed west to mine California's rich veins of venture capital, he has far exceeded them by now. Fortune came first to the CEO of Incyte Genomics, who helped co-found the company in 1991. Today, Incyte supplies 18 of the world's 20 largest pharmaceutical companies with the genomic information that has come to play a vital role in drug discovery. And, increasingly, Whitfield now also finds himself in the public eye.